STATEMENT OF CONSOLIDATED CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Oct. 31, 2015	Oct. 31, 2014	Oct. 31, 2013
Cash Flows from Operating Activities
Net income	$ 1,940.9	$ 3,163.3	$ 3,537.6
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	55.4	38.1	20.5
Provision for depreciation and amortization	1,382.4	1,306.5	1,140.3
Impairment charges	34.8	95.9	102.0
Share-based compensation expense	66.1	78.5	80.7
Undistributed earnings of unconsolidated affiliates	(1.0)	9.3	9.1
Credit for deferred income taxes	(18.4)	(280.1)	(172.6)
Changes in assets and liabilities:
Trade, notes and financing receivables related to sales	811.6	(749.0)	(1,510.2)
Insurance receivables	333.4	(149.9)	263.4
Inventories	(691.4)	(297.9)	(728.4)
Accounts payable and accrued expenses	(503.6)	(137.1)	217.1
Accrued income taxes payable/receivable	(137.6)	342.6	80.4
Retirement benefits	427.5	336.9	262.0
Other	40.2	(231.2)	(47.6)
Net cash provided by operating activities	3,740.3	3,525.9	3,254.3
Cash Flows from Investing Activities
Collections of receivables (excluding receivables related to sales)	14,919.7	15,319.1	14,088.0
Proceeds from maturities and sales of marketable securities	860.7	1,022.5	843.9
Proceeds from sales of equipment on operating leases	1,049.4	1,091.5	936.7
Proceeds from sales of businesses, net of cash sold	149.2	345.8	22.0
Cost of receivables acquired (excluding receivables related to sales)	(14,996.5)	(17,240.4)	(17,011.7)
Purchases of marketable securities	(154.9)	(614.6)	(1,026.3)
Purchases of property and equipment	(694.0)	(1,048.3)	(1,158.4)
Cost of equipment on operating leases acquired	(2,132.1)	(1,611.0)	(1,216.9)
Acquisitions of businesses, net of cash acquired			(83.5)
Other	(60.2)	(145.6)	(214.5)
Net cash used for investing activities	(1,058.7)	(2,881.0)	(4,820.7)
Cash Flows from Financing Activities
Increase in total short-term borrowings	501.6	89.2	2,749.4
Proceeds from long-term borrowings	5,711.0	8,232.0	4,734.0
Payments of long-term borrowings	(4,863.2)	(5,209.1)	(4,958.5)
Proceeds from issuance of common stock	172.1	149.5	174.5
Repurchases of common stock	(2,770.7)	(2,731.1)	(1,531.4)
Dividends paid	(816.3)	(786.0)	(752.9)
Excess tax benefits from share-based compensation	18.5	30.8	50.7
Other	(72.1)	(63.6)	(59.3)
Net cash (used for) provided by financing activities	(2,119.1)	(288.3)	406.5
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(187.3)	(73.6)	11.7
Net Increase (Decrease) in Cash and Cash Equivalents	375.2	283.0	(1,148.2)
Cash and Cash Equivalents at Beginning of Year	3,787.0	3,504.0	4,652.2
Cash and Cash Equivalents at End of Year	$ 4,162.2	$ 3,787.0	$ 3,504.0